Highlights and Quick Summary
- Other current liabilities for the quarter ending October 31, 2022 was $970 Thousand (a 163.13% increase compared to previous quarter)
- Year-over-year quarterly Other current liabilities increased by 124.91%
- Annual Other current liabilities for 2022 was $942 Thousand (a 68.06% increase from previous year)
- Annual Other current liabilities for 2021 was $561 Thousand (a -83.54% decrease from previous year)
- Annual Other current liabilities for 2020 was $3.41 Million (a 347.78% increase from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current liabilities of BRIACELL THERAP
Most recent Other current liabilitiesof BCTX including historical data for past 10 years.Interactive Chart of Other current liabilities of BRIACELL THERAP
BRIACELL THERAP Other current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.97 | $0.37 | $0.6 | $0.94 |
| 2021 | – | $0.43 | $0.17 | $3.46 | $0.56 |
| 2020 | $3.42 | $3.41 | $2.98 | $2.59 | $3.41 |
| 2019 | – | – | – | – | $0.76 |
| 2018 | – | – | – | – | $0.22 |
| 2017 | – | – | – | $0.48 | $0.48 |
| 2016 | – | – | – | – | $0.05 |
| 2014 | $2.0 | $1.75 | – | – | $1.75 |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology